Glympse Bio is a clinical stage company developing novel, non-invasive, urine-based tests to detect nonalcoholic steatohepatitis (NASH) and cancer.Glympse Bio | Catalio Capital Managementwww.cataliocapital.com/portfolio/glympse-bio...
N/A
Technology
2015
Founded
N/A
Employees
AI R&D Pharma (DPI)
Industry
Visual (Placeholder)
Profile Information
Name
Glympse Bio
Industry
AI R&D Pharma (DPI)
Technology
N/A
Location
Cambridge, Cambridgeshire, Cambridgeshire and Peterborough, England, United Kingdom